The Promise of Bacteriophage Therapy Rekindled but Hurdles Remain
Antibiotic resistance is a mounting public health concern with the CDC estimating the annual added cost of treating antibiotic-resistant infections at $20 billion in the US alone. The CDC also estimates that 50-70% of hospital-acquired infections are now resistant to first-line antibiotics. Given the dearth of new classes of antibiotics, drug companies are looking at non-traditional approaches … Read more